172 related articles for article (PubMed ID: 20426858)
41. Melanoma of the Vulva and Vagina: Surgical Management and Outcomes Based on a Clinicopathologic Reviewof 68 Cases.
Sinasac SE; Petrella TM; Rouzbahman M; Sade S; Ghazarian D; Vicus D
J Obstet Gynaecol Can; 2019 Jun; 41(6):762-771. PubMed ID: 30391279
[TBL] [Abstract][Full Text] [Related]
42. Long-term treatment outcomes and prognosis of mucosal melanoma of the head and neck: 161 cases from a single institution.
Sun S; Huang X; Gao L; Zhang Y; Luo J; Zhang S; Wang K; Qu Y; Wu R; Liu Q; Xiao J; Xu G; Yi J
Oral Oncol; 2017 Nov; 74():115-122. PubMed ID: 29103739
[TBL] [Abstract][Full Text] [Related]
43. Prognostic factors in 161 patients with mucosal melanoma: a study of German Central Malignant Melanoma Registry.
Sarac E; Amaral T; Keim U; Leiter U; Forschner A; Eigentler TK; Garbe C
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2021-2025. PubMed ID: 32078189
[TBL] [Abstract][Full Text] [Related]
44. Predictors of survival in head and neck mucosal melanoma.
Schmidt MQ; David J; Yoshida EJ; Scher K; Mita A; Shiao SL; Ho AS; Zumsteg ZS
Oral Oncol; 2017 Oct; 73():36-42. PubMed ID: 28939074
[TBL] [Abstract][Full Text] [Related]
45. Clinicopathologic Features and Prognostic Factors of Primary Cutaneous Melanoma: a Multicenter Study in Korea.
Kim JE; Chung BY; Sim CY; Park AY; Lee JS; Whang KU; Park YL; Kim HO; Park CW; Lee SY
J Korean Med Sci; 2019 Apr; 34(16):e126. PubMed ID: 31020815
[TBL] [Abstract][Full Text] [Related]
46. Surgery and adjuvant therapies in the treatment of stage IV melanoma: our experience in 84 patients.
Tauceri F; Mura G; Roseano M; Framarini M; Ridolfi L; Verdecchia GM
Langenbecks Arch Surg; 2009 Nov; 394(6):1079-84. PubMed ID: 18317795
[TBL] [Abstract][Full Text] [Related]
47. A study of the clinical characteristics and prognosis of advanced mucosal and cutaneous melanoma in a Chinese population.
Zhang Y; Fu X; Qi Y; Gao Q
Immunotherapy; 2019 Feb; 11(2):91-99. PubMed ID: 30511592
[TBL] [Abstract][Full Text] [Related]
48. Time-varying pattern of recurrence risk for localized melanoma in China.
Wen X; Li D; Zhao J; Li J; Yang T; Ding Y; Peng R; Zhu B; Huang F; Zhang X
World J Surg Oncol; 2020 Jan; 18(1):6. PubMed ID: 31901239
[TBL] [Abstract][Full Text] [Related]
49. Head and neck mucosal malignant melanoma: clinicopathologic correlation with contemporary review of prognostic indicators.
Kerr EH; Hameed O; Lewis JS; Bartolucci AA; Wang D; Said-Al-Naief N
Int J Surg Pathol; 2012 Feb; 20(1):37-46. PubMed ID: 21862490
[TBL] [Abstract][Full Text] [Related]
50. Clinical Outcomes and Prognostic Factors in Gastric Carcinoma Patients with Curative Surgery Followed by Adjuvant Treatment: Real-World Scenario.
Kapoor R; Dracham CB; G Y S; Khosla D; Dey T; Elangovan A; Madan R; Yadav BS; Kumar N
J Gastrointest Cancer; 2021 Jun; 52(2):616-624. PubMed ID: 32535755
[TBL] [Abstract][Full Text] [Related]
51. Radiotherapy after surgical resection for head and neck mucosal melanoma.
Wu AJ; Gomez J; Zhung JE; Chan K; Gomez DR; Wolden SL; Zelefsky MJ; Wolchok JD; Carvajal RD; Chapman PB; Wong RJ; Shaha AR; Kraus DH; Shah JP; Lee NY
Am J Clin Oncol; 2010 Jun; 33(3):281-5. PubMed ID: 19823070
[TBL] [Abstract][Full Text] [Related]
52. Radiation therapy for mucosal melanoma of the head and neck.
Christopherson K; Malyapa RS; Werning JW; Morris CG; Kirwan J; Mendenhall WM
Am J Clin Oncol; 2015 Feb; 38(1):87-9. PubMed ID: 23563215
[TBL] [Abstract][Full Text] [Related]
53. Outcomes of mucosal melanoma of the head and neck.
Frakes JM; Strom TJ; Naghavi AO; Trotti A; Rao NG; McCaffrey JC; Otto KJ; Padhya T; Caudell JJ
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):268-73. PubMed ID: 26597431
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study.
Arzu Yaşar H; Turna H; Esin E; Murat Sedef A; Alkan A; Oksuzoglu B; Ozdemir N; Sendur MN; Sezer A; Kılıckap S; Utkan G; Akbulut H; Celik I; Abalı H; Urun Y
J Oncol Pharm Pract; 2020 Mar; 26(2):267-272. PubMed ID: 30924738
[TBL] [Abstract][Full Text] [Related]
55. Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients.
Drepper H; Köhler CO; Bastian B; Breuninger H; Bröcker EB; Göhl J; Groth W; Hermanek P; Hohenberger W; Lippold A
Cancer; 1993 Aug; 72(3):741-9. PubMed ID: 8334626
[TBL] [Abstract][Full Text] [Related]
56. Survival after surgical resection of isolated pulmonary metastases from malignant melanoma.
Andrews S; Robinson L; Cantor A; DeConti RC
Cancer Control; 2006 Jul; 13(3):218-23. PubMed ID: 16885918
[TBL] [Abstract][Full Text] [Related]
57. A retrospective study of 1- versus 2-cm excision margins for cutaneous malignant melanomas thicker than 2 mm.
Hunger RE; Angermeier S; Seyed Jafari SM; Ochsenbein A; Shafighi M
J Am Acad Dermatol; 2015 Jun; 72(6):1054-9. PubMed ID: 25877659
[TBL] [Abstract][Full Text] [Related]
58. Recurrence and Survival Outcomes After Percutaneous Thermal Ablation of Oligometastatic Melanoma.
White ML; Atwell TD; Kurup AN; Schmit GD; Carter RE; Geske JR; Kottschade LA; Pulido JS; Block MS; Jakub JW; Callstrom MR; Markovic SN
Mayo Clin Proc; 2016 Mar; 91(3):288-96. PubMed ID: 26827235
[TBL] [Abstract][Full Text] [Related]
59. Adjuvant radiation and survival following surgical resection of sinonasal melanoma.
Ajmani GS; Liederbach E; Kyrillos A; Wang CH; Pinto JM; Bhayani MK
Am J Otolaryngol; 2017; 38(6):663-667. PubMed ID: 28877859
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
